4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000064
EVP, Chf Clinical Develop Ofcr sold 6,523 shares at $32.79 ($213,889)
- EVP, Chf Clinical Develop Ofcr acquired 17,372 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Schneider Eugene · EVP, Chf Clinical Develop Ofcr
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-15 | Exercise or conversion : show line 1 in the form | +17,372 | 65,031 | D | ||
| 2025-01-16 | Sale : show line 2 in the form | −6,523 | $32.79 | $213,889 | 58,508 | D |
| Open-market sales · 6,523 sh · avg $32.79 · $213,889 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-15 | Grant or award : show line 3 in the form Performance Restricted Stock Units | +22,000 | 65,437 | D |
| 2025-01-15 | Grant or award : show line 4 in the form Restricted Stock Unit | +33,000 | 78,308 | D |
| 2025-01-15 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −17,372 | 60,936 | D |
Loading xslF345X05/edgardoc.xml…